Prognostic Significance of Minimal/Measurable Residual Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia
2021 ◽
Vol 27
(3)
◽
pp. S130-S131
2019 ◽
Vol 25
(10)
◽
pp. 1925-1932
◽
2018 ◽
Vol 97
(11)
◽
pp. 2185-2194
◽
2019 ◽
Vol 16
(2)
◽
pp. 152-158
◽
2016 ◽
Vol 58
(5)
◽
pp. 1135-1143
◽
2005 ◽
Vol 36
(3)
◽
pp. 183-191
◽